Methyl iodide → HCID 71116039, compound
Reaction equation
[F:1][C:2]1[CH:27]=[C:26]([S:28]([CH3:31])(=[O:30])=[O:29])[CH:25]=[CH:24][C:3]=1[CH2:4][O:5][CH2:6][C@@H:7]1[CH2:9][C@@H:8]1[CH:10]1[CH2:15][CH2:14][N:13]([C:16]2[N:21]=[CH:20][C:19]([CH2:22][OH:23])=[CH:18][N:17]=2)[CH2:12][CH2:11]1.[H-].[Na+].[CH3:34]I>C(#N)C.CCOC(C)=O>[F:1][C:2]1[CH:27]=[C:26]([S:28]([CH3:31])(=[O:30])=[O:29])[CH:25]=[CH:24][C:3]=1[CH2:4][O:5][CH2:6][C@@H:7]1[CH2:9][C@@H:8]1[CH:10]1[CH2:11][CH2:12][N:13]([C:16]2[N:21]=[CH:20][C:19]([CH2:22][O:23][CH3:34])=[CH:18][N:17]=2)[CH2:14][CH2:15]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
The product of step A (20 mg, 0.044 mmol) was dissolved in acetonitrile (4 mL) at RT under N2 and sodium hydride (10 mg of a 60% dispersion in oil, 0.25 mmol) was added followed by CH3I (31.6 mg, 0.222 mmol). The mixture was stirred at RT overnight. The mixture was diluted with EtOAc, washed with sat. NH4Cl, dried over MgSO4, filtered and evaporated in vacuo. The crude material was purified by preparative thin-layer chromatography (70% EtOAc in hexane) to yield the title compound. 1H NMR (500 MHz, CDCl3) δ 8.30 (s, 2H), 7.78 (dd, 1H), 7.73 (m, 1H), 7.67 (dd, 1H), 4.80-4.64 (m, 4H), 4.28 (s, 2H), 3.71 (dd, 1H), 3.61-3.54 (m, 1H), 3.37 (s, 3H), 3.08 (s, 3H), 2.93-2.80 (m, 2H), 1.96 (d, 1H), 1.85 (d, 1H), 1.43-1.22 (m, 3H), 1.15-1.04 (m, 1H), 0.94-0.71 (m, 2H), 0.12-0.08 (m, 1H). MS (ESI) m/z 464 [M+H]+. GPR119 Human EC50: 1.6 nM
Workup
- washwashed with sat. NH4Cl
- dry with materialdried over MgSO4
- filtrationfiltered
- customevaporated in vacuo
- customThe crude material was purified by preparative thin-layer chromatography (70% EtOAc in hexane)
Sources & evidence
- ORD record
- ord-55aac7e904084cea900e60002f6a8666
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09006228B2
Reaction notes
Loading…